Published in J Infect on March 01, 1992
Prophylaxis and treatment of anthrax in pregnant women. Obstet Gynecol (2013) 0.77
Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol (1999) 3.35
Intraoperative bacterial contamination in operations for joint replacement. J Bone Joint Surg Br (1999) 3.07
Failure of chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet (1991) 3.03
The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncol Nurs Forum (1998) 2.39
Evaluations of aesthetic results in breast reconstruction: an analysis of reliability. Ann Plast Surg (1996) 1.90
Leucocyte esterase-nitrite screening method for pyuria and bacteriuria. J Clin Pathol (1985) 1.67
Determinants of patient satisfaction in postmastectomy breast reconstruction. Plast Reconstr Surg (2000) 1.67
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Antimicrob Agents Chemother (1997) 1.66
Utility of PCR in diagnosing pulmonary tuberculosis. J Clin Microbiol (1996) 1.64
Tuberculous pericarditis confirmed by DNA amplification. Lancet (1991) 1.54
Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys (2001) 1.53
Diagnosis of silicone gel breast implant rupture by ultrasonography. Plast Reconstr Surg (1996) 1.43
The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS (1996) 1.41
The intracellular pharmacology of antiretroviral protease inhibitors. J Antimicrob Chemother (2004) 1.35
P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance? AIDS (2001) 1.35
Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis. J Clin Microbiol (1998) 1.29
Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol (2004) 1.18
The role of therapeutic drug monitoring in treatment of HIV infection. Br J Clin Pharmacol (2001) 1.14
Outcome of varicella pneumonitis in immunocompetent adults requiring treatment in a high dependency unit. J Infect (2001) 1.10
Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro. Antivir Chem Chemother (2000) 1.08
Predictors of patient satisfaction in an outpatient plastic surgery clinic. Ann Plast Surg (1999) 1.07
The role of therapeutic drug monitoring in treatment of HIV infection. Br J Clin Pharmacol (2001) 1.03
A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect (1999) 1.03
The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br J Pharmacol (2009) 1.01
Salmonella screening of pregnant women. J Hosp Infect (1987) 0.99
Is coagulase-negative staphylococcal bacteraemia in neonates a consequence of mechanical ventilation? J Hosp Infect (1985) 0.99
TB PCR in the early diagnosis of tuberculous meningitis: evaluation of the Roche semi-automated COBAS Amplicor MTB test with reference to the manual Amplicor MTB PCR test. . Tuber Lung Dis (2000) 0.99
Pulmonary tuberculosis due to Mycobacterium bovis. Thorax (1986) 0.96
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy. HIV Med (2010) 0.96
Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers. Antimicrob Agents Chemother (2000) 0.95
Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection. Ther Drug Monit (2000) 0.95
Serodiagnosis of pericardial tuberculosis. QJM (1995) 0.93
Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. AIDS Res Hum Retroviruses (2000) 0.93
P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals. J Antimicrob Chemother (2002) 0.93
The management of Pneumocystis carinii pneumonia. Br J Clin Pharmacol (1999) 0.93
Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity. Pharmacogenetics (2000) 0.91
Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir. Br J Pharmacol (2008) 0.91
Expression of P-glycoprotein and multidrug resistance-associated protein in healthy volunteers and HIV-infected patients. AIDS Res Hum Retroviruses (2001) 0.90
Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations. Antimicrob Agents Chemother (2011) 0.90
Constipation in the elderly. Postgrad Med J (1968) 0.90
Optimal sampling strategies for early pharmacodynamic measures in tuberculosis. J Antimicrob Chemother (2006) 0.90
Valvular tuberculous endocarditis: a case report and review of the literature. J Infect (1990) 0.90
Zidovudine phosphorylation determined sequentially over 12 months in human immunodeficiency virus-infected patients with or without previous exposure to antiretroviral agents. Antimicrob Agents Chemother (2001) 0.89
Prevalence of cortisol deficiency in late HIV disease. J Infect (1995) 0.87
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group. Antimicrob Agents Chemother (2000) 0.87
Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. AIDS (1996) 0.86
Management of non-respiratory tuberculosis. Lancet (1986) 0.86
Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression. J Antimicrob Chemother (2003) 0.84
Detection of ABCC2, CYP2B6 and CYP3A4 in human peripheral blood mononuclear cells using flow cytometry. J Immunol Methods (2008) 0.84
Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression. AIDS (1997) 0.84
Bovine variants of Mycobacterium tuberculosis isolated in Liverpool during the period 1969 to 1983: an epidemiological survey. Q J Med (1986) 0.83
Influence of prior exposure to zidovudine on stavudine phosphorylation in vivo and ex vivo. Antimicrob Agents Chemother (2001) 0.83
Quantitative bacteriology of peripheral venous cannulae in neonates. J Hosp Infect (1985) 0.83
The clinical utility of HIV outpatient pharmacist prescreening to reduce medication error and assess adherence. Int J STD AIDS (2013) 0.83
HIV induces deletion of T cell receptor variable gene product-specific T cells. Clin Exp Immunol (1993) 0.82
Prospective analysis of psychosocial outcomes after breast reconstruction: cross-cultural comparisons of 1-year postoperative results. J Plast Reconstr Aesthet Surg (2007) 0.81
Superficial tuberculous lymphadenitis in Merseyside: 1969-1984. J Hyg (Lond) (1985) 0.81
Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system? Int J STD AIDS (2012) 0.81
Utility of therapeutic drug monitoring in the management of HIV-infected pregnant women in receipt of lopinavir. Int J STD AIDS (2011) 0.81
Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation. J Antimicrob Chemother (2013) 0.81
In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy. AIDS Res Hum Retroviruses (1997) 0.81
Lack of skin test reactivity to common mycobacterial antigens in human immunodeficiency virus infected individuals with high CD4 counts. Thorax (1996) 0.81
Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo. J Immunol Methods (2002) 0.80
Is mammography useful in screening for local recurrences in patients with TRAM flap breast reconstruction after mastectomy for multifocal DCIS? Ann Surg Oncol (1998) 0.80
Tuberculosis peritonitis: diagnostic value of the ascitic/blood glucose ratio. Tubercle (1984) 0.80
Disseminated Penicillium marneffei in a patient infected with human immunodeficiency virus. Int J STD AIDS (2000) 0.79
Visceral leishmaniasis (Kala-azar) in two patients with HIV-1 infection: atypical features and response to therapy. J Infect (1998) 0.79
A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets. J Immunol Methods (2003) 0.79
Mammographic appearance of recurrent breast carcinoma in six patients with TRAM flap breast reconstructions. Radiology (1998) 0.79
The integrin-triggered rescue of T lymphocyte apoptosis is blocked in HIV-1-infected individuals. J Immunol (1997) 0.79
Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis. AIDS (1993) 0.79
The relationships of ABCB1 3435C>T and CYP2B6 516G>T with high-density lipoprotein cholesterol in HIV-infected patients receiving Efavirenz. Clin Pharmacol Ther (2009) 0.78
Severe community acquired pneumonia associated with a desquamating rash due to group A beta-haemolytic streptococcus. J Infect (1994) 0.78
Double free-flap reconstruction of massive defects involving the lip, chin, and mandible. Microsurgery (1998) 0.78
Influenza-like episodes in HIV-positive patients: the role of viral and 'atypical' infections. AIDS (1998) 0.78
Prophylactic effect of co-trimoxazole for Mycobacterium avium complex infection: a previously unreported benefit. Clin Infect Dis (1994) 0.78
Implementation and evaluation of a clinical pathway for TRAM breast reconstruction. Plast Reconstr Surg (2000) 0.78
The cardiologist in the Third World. Br Med J (Clin Res Ed) (1984) 0.78
Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patients. J Med Virol (2000) 0.78
Participants in HIV clinical trials in Europe. Int J STD AIDS (2001) 0.77
The diagnostic value of glucose in pleural/peritoneal fluid in tuberculosis. Indian J Pediatr (1986) 0.77
Humoral response to mycobacterial heat shock proteins in patients with constrictive pericarditis caused by tuberculosis and its implications for pathogenesis. Clin Diagn Lab Immunol (1994) 0.77
Controversies in anti-retroviral therapy of adults. J Antimicrob Chemother (1995) 0.77
Growth hormone deficiency coupled with hypogonadism in AIDS. Clin Endocrinol (Oxf) (1994) 0.76
Premature delivery and group B streptococcal bacteriuria. Lancet (1984) 0.76
Probable toxic shock syndrome with primary staphylococcal pneumonia. J Infect (1985) 0.75
Changing face of AIDS. BMJ (1991) 0.75
Recurrent cerebral abscess in hereditary hemorrhagic telangiectasia. J Neurol Neurosurg Psychiatry (1983) 0.75
Malaria prophylaxis. Mefloquine should be first choice. BMJ (1993) 0.75
Indifferent streptococci in sticky eyes of neonates. J Clin Pathol (1986) 0.75
Tuberculous meningitis due to Mycobacterium bovis: a report of two cases. Postgrad Med J (1986) 0.75
Serum measurements of soluble CD23 in HIV infection. Immunology (1993) 0.75
Difficulties in the diagnosis of acquired immune deficiency syndrome. J Clin Pathol (1984) 0.75
Induction of adrenal suppression by megestrol acetate. Ann Intern Med (1996) 0.75
Gastric washing smears--help or hindrance? Tubercle (1989) 0.75